Tech Company Financing Transactions
Nintx Funding Round
On 12/16/2024, Nintx announced $10 million in funding from Fundo Pitanga.
Transaction Overview
Company Name
Announced On
12/16/2024
Transaction Type
Venture Equity
Amount
$10,000,000
Round
Undisclosed
Investors
Proceeds Purpose
The company intends to use the funds to support its plans for the coming years, which include accelerating the R&D of eight new drug programs, hiring researchers, introducing new technologies, and expanding the laboratory.
Company Information
Company Status
Private & Independent
Industry
Life Sciences
Mailing Address
Av. Nações Unidas, 18801, conj 809, Jd Dom Bosco
São Paulo, 04757-025
Brazil
São Paulo, 04757-025
Brazil
Phone
Undisclosed
Website
Email Address
Not Recorded
Overview
Originated in Brazil at the beginning of 2021 to translate complex biological interactions (plants and microorganisms) into novel therapies, Nintx (Next Innovative Therapeutics) believes plant-based natural products bear huge potential to serve as a superb platform to modulate human biological targets and the microbiome concomitantly, affording therapies for multifactorial diseases (multi-target therapies).
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Miller Freitas
Chief Scientific Officer
Cristiano Guimarães
Co-Founder
Stephani Saverio
Browse more venture capital transactions:
Prev: 12/16/2024: BILT venture capital transaction
Next: 12/16/2024: Fluid Biomed venture capital transaction
Share this article
About Our VC Transactions Data
We document all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs